Fundamental biology of E2F transcription factors: investigating the role of arginine methylation

E2F转录因子的基础生物学:研究精氨酸甲基化的作用

基本信息

  • 批准号:
    BB/P009212/1
  • 负责人:
  • 金额:
    $ 83.62万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2017
  • 资助国家:
    英国
  • 起止时间:
    2017 至 无数据
  • 项目状态:
    已结题

项目摘要

Growth and division of animal cells requires gene expression to be turned on and off in a coordinated fashion. The process of cell division is called the cell cycle, during which chromosomes are first copied and then one cell divides into two. A major point of control occurs during the first G1 phase, where cells commit to replicate their chromosomes and divide or alternatively exit the cell cycle. In normal cells, the cell cycle is a tightly regulated process, but frequently becomes awry in human disease. The key proteins involved, the retinoblastoma tumour suppressor protein pRb and its crucial target E2F, govern progress through G1, and the commitment of cells to divide. This research addresses the mechanisms which are responsible for normal cell cycle regulation focussing on new levels of enzymatic control which influence the regulatory properties of E2F, focussing on the E2F-1 subunit, which exhibits some profoundly interesting and unusual biological properties; for example, it is able to prompt cell growth and survival, and conversely stimulate cell death. Nothing is really known about the molecular mechanisms which control these contrasting biological outcomes of E2F-1 activity, which is the focus of this application. Specifically, the programme will dissect the molecular mechanisms and cellular processes through which E2F-1 exerts its biological effects in cells. We will concentrate on the mechanisms which endow E2F with its opposing biological properties, and probe the cellular pathways and molecular processes that are responsible. Our experimental approach uses advanced methodologies to address important questions on how E2F exerts its effects at the genome and proteome level, and we work with a group of expert collaborators to achieve these aims. Our research has the overarching aim of delivering a detailed understanding of the role of E2F in normal cells, and the mechanisms which are responsible for controlling its distinct biological roles. The study is very likely to illuminate new mechanisms and information that is relevant to human disease.
动物细胞的生长和分裂需要以协调的方式开启和关闭基因表达。细胞分裂的过程被称为细胞周期,在这个过程中,染色体首先被复制,然后一个细胞分裂成两个。一个主要的控制点发生在第一个G1期,在这个阶段,细胞承诺复制它们的染色体并分裂或退出细胞周期。在正常细胞中,细胞周期是一个严格调控的过程,但在人类疾病中经常变得不正常。参与其中的关键蛋白是视网膜母细胞瘤肿瘤抑制蛋白PRB及其关键靶点E2F,它们通过G1和细胞分裂的承诺来控制进展。这项研究探讨了正常细胞周期调控的机制,重点是影响E2F调节特性的酶调控的新水平,重点是E2F-1亚单位,它表现出一些非常有趣和不寻常的生物学特性,例如,它能够促进细胞生长和存活,并反过来刺激细胞死亡。关于控制E2F-1活性的这些不同生物学结果的分子机制尚不真正清楚,这是本应用的重点。具体地说,该计划将剖析E2F-1在细胞中发挥其生物学效应的分子机制和细胞过程。我们将集中于赋予E2F相反生物学特性的机制,并探索相关的细胞途径和分子过程。我们的实验方法使用先进的方法来解决E2F如何在基因组和蛋白质组水平上发挥作用的重要问题,我们与一组专家合作者合作来实现这些目标。我们的研究的首要目标是详细了解E2F在正常细胞中的作用,以及负责控制其不同生物学作用的机制。这项研究很有可能阐明与人类疾病相关的新机制和信息。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Linking H1 with chromatin and growth control.
  • DOI:
    10.1080/23723556.2017.1360977
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Munro S;La Thangue NB
  • 通讯作者:
    La Thangue NB
CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation.
CBP/p300溴化构域在异常赖氨酸乙酰化后调节淀粉样淀粉样蛋白样蛋白聚集。
  • DOI:
    10.1016/j.chembiol.2016.11.009
  • 发表时间:
    2017-01-19
  • 期刊:
  • 影响因子:
    8.6
  • 作者:
    Olzscha H;Fedorov O;Kessler BM;Knapp S;La Thangue NB
  • 通讯作者:
    La Thangue NB
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response.
  • DOI:
    10.1038/s41467-023-36826-0
  • 发表时间:
    2023-02-25
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Barczak, Wojciech;Carr, Simon M. M.;Liu, Geng;Munro, Shonagh;Nicastri, Annalisa;Lee, Lian Ni;Hutchings, Claire;Ternette, Nicola;Klenerman, Paul;Kanapin, Alexander;Samsonova, Anastasia;La Thangue, Nicholas B. B.
  • 通讯作者:
    La Thangue, Nicholas B. B.
Linker Histone H1.2 Directs Genome-wide Chromatin Association of the Retinoblastoma Tumor Suppressor Protein and Facilitates Its Function.
  • DOI:
    10.1016/j.celrep.2017.05.053
  • 发表时间:
    2017-06-13
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Munro S;Hookway ES;Floderer M;Carr SM;Konietzny R;Kessler BM;Oppermann U;La Thangue NB
  • 通讯作者:
    La Thangue NB
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.
  • DOI:
    10.1016/j.chembiol.2017.02.006
  • 发表时间:
    2017-03-16
  • 期刊:
  • 影响因子:
    8.6
  • 作者:
    Tumber A;Nuzzi A;Hookway ES;Hatch SB;Velupillai S;Johansson C;Kawamura A;Savitsky P;Yapp C;Szykowska A;Wu N;Bountra C;Strain-Damerell C;Burgess-Brown NA;Ruda GF;Fedorov O;Munro S;England KS;Nowak RP;Schofield CJ;La Thangue NB;Pawlyn C;Davies F;Morgan G;Athanasou N;Müller S;Oppermann U;Brennan PE
  • 通讯作者:
    Brennan PE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas La Thangue其他文献

Nicholas La Thangue的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas La Thangue', 18)}}的其他基金

The E2F pathway: new levels of control and regulation
E2F 途径:控制和监管的新水平
  • 批准号:
    G1000807-E01/1
  • 财政年份:
    2011
  • 资助金额:
    $ 83.62万
  • 项目类别:
    Research Grant
The E2F pathway of growth control
生长控制的E2F途径
  • 批准号:
    G0500905/1
  • 财政年份:
    2006
  • 资助金额:
    $ 83.62万
  • 项目类别:
    Research Grant

相似国自然基金

组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
  • 批准号:
    82370988
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
Journal of Integrative Plant Biology
  • 批准号:
    31024801
  • 批准年份:
    2010
  • 资助金额:
    24.0 万元
  • 项目类别:
    专项基金项目
Computational Methods for Analyzing Toponome Data
  • 批准号:
    60601030
  • 批准年份:
    2006
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Noncanonical E2F Regulation in the Neuronal DNA Damage Response
神经元 DNA 损伤反应中的非典型 E2F 调节
  • 批准号:
    10752078
  • 财政年份:
    2023
  • 资助金额:
    $ 83.62万
  • 项目类别:
Single-cell dynamics of E2F and APC/CCdh1 coordination that regulate the proliferation-quiescence decision
E2F 和 APC/CCdh1 协调的单细胞动力学调节增殖-静止决策
  • 批准号:
    10676530
  • 财政年份:
    2023
  • 资助金额:
    $ 83.62万
  • 项目类别:
Project 3: Defining and targeting mechanisms of E2F transcription factor regulation
项目3:E2F转录因子调控的定义和靶向机制
  • 批准号:
    10332382
  • 财政年份:
    2022
  • 资助金额:
    $ 83.62万
  • 项目类别:
Project 3: Defining and targeting mechanisms of E2F transcription factor regulation
项目3:E2F转录因子调控的定义和靶向机制
  • 批准号:
    10597169
  • 财政年份:
    2022
  • 资助金额:
    $ 83.62万
  • 项目类别:
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Rb/E2f 相互作用破坏后肿瘤发生的机制
  • 批准号:
    10653684
  • 财政年份:
    2021
  • 资助金额:
    $ 83.62万
  • 项目类别:
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Rb/E2f 相互作用破坏后肿瘤发生的机制
  • 批准号:
    10364702
  • 财政年份:
    2021
  • 资助金额:
    $ 83.62万
  • 项目类别:
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
Rb/E2f 相互作用破坏后肿瘤发生的机制
  • 批准号:
    10210641
  • 财政年份:
    2021
  • 资助金额:
    $ 83.62万
  • 项目类别:
Temporal E2F Dynamics and Cell-Fate Decisions in Single Mammalian Cells
单个哺乳动物细胞中的时间 E2F 动力学和细胞命运决策
  • 批准号:
    8631365
  • 财政年份:
    2014
  • 资助金额:
    $ 83.62万
  • 项目类别:
Temporal E2F Dynamics and Cell-Fate Decisions in Single Mammalian Cells
单个哺乳动物细胞中的时间 E2F 动力学和细胞命运决策
  • 批准号:
    9281550
  • 财政年份:
    2014
  • 资助金额:
    $ 83.62万
  • 项目类别:
A systems biology study of E2F and NF-kappaB cross-talk
E2F 和 NF-kappaB 串扰的系统生物学研究
  • 批准号:
    BB/H013725/2
  • 财政年份:
    2010
  • 资助金额:
    $ 83.62万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了